The Power of Information

National Drinking Water Database


National Drinking Water Database - Chemical Contaminants

Benzo[a]anthracene


Status: Unregulated - EPA has not established a maximum legal limit in tapwater for this contaminant.

Benzo[a]anthracene is a polycyclic aromatic hydrocarbon (PAH) released from combustion of fossil fuels and waste incinerators.

 
Detected
Found above
health guidelines
Found above
legal limit
States
4
4
-
Water utilities
5
4
-
People Served
621,527
421,527
-

Health Concerns for Benzo[a]anthracene:


Benzo[a]anthracene Exposure by State

Water utilities in 4 states have reported detecting Benzo[a]anthracene in treated tap water since 2004, according to EWG's analysis of water quality data supplied by state water agencies.

StateWater Suppliers with Benzo[a]anthracene contaminationWater suppliers reporting Benzo[a]anthracene above health-based limits
SystemsPopulationSystemsPopulation
New Jersey1217,2301217,230
Delaware1201,0001201,000
California2202,77212,772
Texas15251525
Total5621,5274421,527

The Most Polluted Communities

5 water utilities reported detecting Benzo[a]anthracene in tap water since 2004, according to EWG's analysis of water quality data supplied by state water agencies

Ranked by highest average Benzo[a]anthracene level

RankSystem Population Served Positive test results of total reported tests Average Level
(Range)
1Lost Hills Utility District
Lost Hills, CA
2,7721 of 20.15 ppb
(0 to 0.3 ppb)
2NJ American Water Company
Shorthills, NJ
217,2301 of 10.13 ppb
(0.13 ppb)
3West Houston Mobile Home Comm
Houston, TX
5251 of 10.06 ppb
(0.06 ppb)
4Artesian Water Company
Newark, DE
201,0001 of 73< 0.01 ppb
(0 to 0.67 ppb)
5Glendale-City, Water Dept.
Glendale, CA
200,0001 of 38< 0.01 ppb
(< .01 to 0.0005 ppb)

Health Based Limits for Benzo[a]anthracene

StandardDescriptionLevel
EPA Human Health Water Quality CriteriaWater quality criteria set by the US EPA provide guidance for states and tribes authorized to establish water quality standards under the Clean Water Act (CWA) to protect human health. These are non-enforceable standards based upon exposure by both drinking water and the contribution of water contamination to other consumed foods. Source: U.S. Environmental Protection Agency.<0.01 ppb

Testing Summary for Benzo[a]anthracene

Are tests routinely required for Benzo[a]anthracene by federal law?No
Water suppliers reporting tests for Benzo[a]anthracene (2004-2009):2,564 of 47,576
Average testing rate for water supplier reporting tests (2004-2009):0.4 per year

Cancer

Type of concern: Reference:
Possible human carcinogen European Union - Classification & Labelling
Possible human carcinogen Amer Conf of Gov't Industrial Hygienists - Carcinogens
Possible human carcinogen EPA Integrated Risk Information System (IRIS)
Possible human carcinogen California EPA Proposition 65
Cancer - strong evidence Proposition 65 List of Carcinogens
Limited evidence of carcinogenicity Int'l Agency for Research on Cancer (IARC) - Carcinogens
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Proceedings of the National Academy of Sciences of the United States of America 1988
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 1998
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology 1987
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Cancer Research 1978
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Cancer Research 1982
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Developments in Toxicology and Environtal Science 1982
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 1995
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Cancer Research 1980
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- JNCI, Journal of the National Cancer Institute 1981
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 1994
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Environmental Mutagenesis 1981
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 1981
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Tokyo Jikeikai Ika Daigaku Zasshi 1986
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Environmental and Molecular Mutagenesis 1988
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Environmental Mutagenesis 1982
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- JNCI, Journal of the National Cancer Institute 1979
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Chemico-Biological Interactions 1972
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Carcinogenesis (London) 1984
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- JNCI, Journal of the National Cancer Institute 1980
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Acta Morphologica Academiae Scientiarum Hungaricae 1979
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 1977
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- International Journal of Cancer 1972
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- British Journal of Cancer 1978
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Toxicology 1980
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Biochemical Pharmacology 1971
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Cancer Letters (Shannon, Ireland) 1990
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 1979
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Chemical Mutagens 1980
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Environmental Mutagenesis 1985
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- British Journal of Cancer 1979
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Toxicology 2004
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 2005
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 2007
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 2004
One or more in vitro tests on mammalian cells show positive mutation results RTECS®- Mutation Research 2008
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Carcinogenesis (London) 1984
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Mutation Research 1987
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Mutation Research 1981
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Cancer Research 1981
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Proceedings of the National Academy of Sciences of the United States of America 1977
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Cancer Research 1973
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Mutation Research 1990
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Mutation Research 1993
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Egyptian Journal of Genetics and Cytology 1975
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Mutation Research 2002
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Mutation Research 2004
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Mutagenesis 2005
One or more in vitro tests non-mammalian cells show positive mutation results RTECS®- Mutation Research 2007
One or more in vitro tests on microorganisms show positive mutation results RTECS®- Mutation Research 1993
One or more in vitro tests on microorganisms show positive mutation results RTECS®- Biochemical Journal 1968
One or more in vitro tests on microorganisms show positive mutation results RTECS®- Huanjing Kexue Xuebao 1984
One or more in vitro tests on microorganisms show positive mutation results RTECS®- Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology 1987

Persistence and bioaccumulation

Type of concern: Reference:
Persistent, bioaccumulative in wildlife and humans EPA Toxic Release Inventory PBTs
Persistent, bioaccumulative in wildlife Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET)
Persistent, bioaccumulative in wildlife Great Lakes BTS (Binational Toxics Strategy) PBTs
Persistent, bioaccumulative in wildlife OSPAR PBTs - Substances of Possible Concern
Persistent, bioaccumulative in wildlife EPA PBTs - Waste Minimization Program (RCRA)

Endocrine disruption

Type of concern: Reference:
Human disruptor - moderate evidence European Commission on Endocrine Disruption
Limited evidence of wildlife and the environment disruption European Commission on Endocrine Disruption

Ecotoxicology

Type of concern: Reference:
Wildlife and environmental toxicity European Union - Classification & Labelling
Wildlife and environmental toxicity EPA Clean Water Act - Priority Pollutants



Government, industry, academic studies and classifications

government/industry list/academic study appears on list as classification(s)
European Union - Classification & LabellingBENZ[A]ANTHRACENE•May cause cancer
•May cause cancer
•Dangerous for the environment
•Very toxic to aquatic organisms
Amer Conf of Gov't Industrial Hygienists - CarcinogensBENZ[A]ANTHRACENE•Suspected human carcinogen (ACGIH classification A2)
EPA Clean Water Act - Priority PollutantsBENZ(A)ANTHRACENE•Priority water pollutant under the Clean Water Act
European Union - Banned or Restricted in CosmeticsBENZ[A]ANTHRACENE•Prohibited in EU cosmetics: must not form part of the composition of cosmetic products
Int'l Agency for Research on Cancer (IARC) - CarcinogensBENZ[A]ANTHRACENE•IARC Group 2B: possible human carcinogen (International Agency for Research on Carcinogens)
Aarhus Protocol on Persistent Organic PollutantsBENZOANTHRACENEObligates Parties to reduce emissions under Aahrus Protocol for Persistent Organic Pollutants
Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET)BENZOANTHRACENE•Persistent, bioaccumulative toxicant under Canada's Accelerated Reduction/Elimination of Toxics program - targeted for elimination or reduction
Great Lakes BTS (Binational Toxics Strategy) PBTsBENZOANTHRACENE•Persistent, bioaccumulative toxicant - Great Lakes Binational Strategy, Tier 2 concern (moderate), targeting for monitoring/testing
OSPAR PBTs - Substances of Possible ConcernBENZOANTHRACENE•Persistent, bioaccumulative toxicant - Oslo-Paris (OSPAR) Convention for the Protection of the Marine Environment of the North-East Atlantic, chemical of concern
EPA Toxic Release Inventory PBTsBENZOANTHRACENE•Persistent, bioaccumulative toxicant - targeted for waste reporting under U.S. Environmental Protection Agency Toxics Release Inventory programs
EPA PBTs - Waste Minimization Program (RCRA)BENZOANTHRACENE•Persistent, bioaccumulative toxicant - Resource Conservation and Recovery Act, priority chemical for voluntary waste/emission reductions
EPA Integrated Risk Information System (IRIS)BENZ[A]ANTHRACENE•Group B2: Probable human carcinogen - sufficient data in animals (EPA classification)
California EPA Proposition 65BENZ[A]ANTHRACENE•Carcinogen: California Proposition 65
Proposition 65 List of CarcinogensBENZ(A)ANTHRACENE•Cancer hazards: recognized
European Commission on Endocrine DisruptionBENZ(A)ANTHRACENEHH-CAT2;WF-CAT2
RTECS®- Acta Morphologica Academiae Scientiarum Hungaricae 1979BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Cytogenetic Analysis (hamster ipr)
• mutagenic - Positive mutation assay: Micronucleus test (hamster ipr)
• mutagenic - Positive mutation assay: sperm (hamster orl)
RTECS®- Biochemical Journal 1968BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Adduct (salmon tes)
RTECS®- Biochemical Pharmacology 1971BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Damage (hamster fbr)
RTECS®- British Journal of Cancer 1978BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Morphological Transform (hamster kdy)
RTECS®- British Journal of Cancer 1979BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Mutation in Mammalian Somatic Cells (hamster lng)
RTECS®- Cancer Letters (Shannon, Ireland) 1990BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Inhibition (hamster oth)
RTECS®- Cancer Research 1973BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: (Drosophila melanogaster par)
RTECS®- Cancer Research 1978BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Unscheduled DNA Synthesis ( human hla)
RTECS®- Cancer Research 1980BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Morphological Transform (rat orl)
RTECS®- Cancer Research 1981BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Phage Inhibition Capacity (Escherichia coli )
RTECS®- Cancer Research 1982BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Inhibition ( human oth)
RTECS®- Carcinogenesis (London) 1984BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Adduct (mouse skn)
RTECS®- Carcinogenesis (London) 1984BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Mutation in Micro-organism (Salmonella typhimurium )
RTECS®- Chemical Mutagens 1980BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Sister Chromatid Exchange (hamster ovr)
RTECS®- Chemico-Biological Interactions 1972BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Adduct (mouse oth)
• mutagenic - Positive mutation assay: other mutation test systems (hamster lng)
RTECS®- Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology 1987BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (other fish oth)
RTECS®- Developments in Toxicology and Environtal Science 1982BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Mutation in Mammalian Somatic Cells ( human lym)
RTECS®- Egyptian Journal of Genetics and Cytology 1975BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Sex Chromosome Loss and Nondisjunction (Drosophila melanogaster par)
RTECS®- Environmental and Molecular Mutagenesis 1988BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Mutation in Micro-organism (mouse lym)
RTECS®- Environmental Mutagenesis 1981BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (rat lvr)
RTECS®- Environmental Mutagenesis 1982BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Morphological Transform (mouse emb)
RTECS®- Environmental Mutagenesis 1985BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Sister Chromatid Exchange (hamster lng)
RTECS®- Huanjing Kexue Xuebao 1984BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (other fish lvr)
RTECS®- International Journal of Cancer 1972BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Morphological Transform (hamster emb)
RTECS®- JNCI, Journal of the National Cancer Institute 1979BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Host-mediated Assay (mouse )
RTECS®- JNCI, Journal of the National Cancer Institute 1979BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Adduct (mouse lvr)
RTECS®- JNCI, Journal of the National Cancer Institute 1980BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Inhibition (mouse oth)
RTECS®- JNCI, Journal of the National Cancer Institute 1981BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Morphological Transform (rat emb)
RTECS®- Mutagenesis 2005BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Mutation in Micro-organism (Salmonella typhimurium )
RTECS®- Mutation Research 1987BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: other mutation test systems (Salmonella typhimurium )
RTECS®- Mutation Research 1990BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: (Drosophila melanogaster orl)
RTECS®- Mutation Research 1993BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA repair (Drosophila melanogaster orl)
RTECS®- Mutation Research 1993BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Micronucleus test (non-mammalian species mul)
RTECS®- Mutation Research 1994BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Adduct (rat itr)
• mutagenic - Positive mutation assay: Sister Chromatid Exchange (rat itr)
RTECS®- Mutation Research 1995BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Micronucleus test (rat itr)
RTECS®- Mutation Research 1998BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Adduct (hamster lng)
RTECS®- Mutation Research 1977BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Mutation in Micro-organism (hamster lng)
RTECS®- Mutation Research 2002BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Damage (Escherichia coli )
RTECS®- Mutation Research 2004BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Damage ( human fbr)
RTECS®- Mutation Research 2004BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Mutation in Micro-organism (Salmonella typhimurium )
RTECS®- Mutation Research 2005BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Micronucleus test (mouse skn)
RTECS®- Mutation Research 2005BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Morphological Transform (mouse emb)
RTECS®- Mutation Research 2007BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: other mutation test systems (rat lvr)
RTECS®- Mutation Research 2007BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Mutation in Micro-organism (Salmonella typhimurium )
RTECS®- Mutation Research 2008BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Damage (hamster fbr)
RTECS®- Mutation Research 1979BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Sister Chromatid Exchange (hamster ipr)
RTECS®- Mutation Research 1981BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Adduct (Escherichia coli )
RTECS®- Mutation Research 1981BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Sister Chromatid Exchange (rat lvr)
RTECS®- Proceedings of the National Academy of Sciences of the United States of America 1977BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Inhibition (other micro-organisms )
RTECS®- Proceedings of the National Academy of Sciences of the United States of America 1988BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: DNA Adduct ( human lym)
RTECS®- Tokyo Jikeikai Ika Daigaku Zasshi 1986BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Micronucleus test (mouse ipr)
RTECS®- Toxicology 1980BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Morphological Transform (hamster lng)
RTECS®- Toxicology 2004BENZ(A)ANTHRACENE• mutagenic - Positive mutation assay: Micronucleus test ( human lvr)



references

government/industry list/academic study reference
European Union - Classification & LabellingCPS&Q (Consumer Products Safety & Quality) formely known as ECB (European Chemicals Bureau). 2008. Classification and Labelling: Chemicals: Annex VI of Directive 67/548/EEC through the 31st ATP.
Amer Conf of Gov't Industrial Hygienists - CarcinogensACGIH (American Conference of Governmental Industrial Hygienists) 2008. ACGIH cancer classification system. www.acgih.org.
EPA Clean Water Act - Priority Pollutants
European Union - Banned or Restricted in CosmeticsEC (European Commission of the European Union). 1999-2006. Enterprise Directorate-General Pharmaceuticals and Cosmetics. The rules governing cosmetic products in the European Union, Volume 1, "Cosmetics legislation."
Int'l Agency for Research on Cancer (IARC) - CarcinogensIARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures).
Aarhus Protocol on Persistent Organic PollutantsAarhus LRTAP. 1998. Aarhus Protocol on Persistent Organic Pollutants (POPs). Geneva Convention on Long-range Transboundary Air Pollution, United Nations Environment Program.
Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET)EC (Environment Canada). 1994. Accelerated Reduction/Elimination of Toxics (ARET). ARET substance list of persistent, bioaccumulative and toxic chemicals.
Great Lakes BTS (Binational Toxics Strategy) PBTsGreat Lakes BTS (Binational Toxics Strategy). 1997. Canada-United States Strategy for the Virtual Elimination of Persistent Toxic Substances in the Great Lakes. Appendix I - Level 1 and Level 2 substances.
OSPAR PBTs - Substances of Possible ConcernOSPAR (Oslo-Paris). 2002. OSPAR List of Substances of Possible Concern. Secondary OSPAR List of Substances of Possible Concern. Secondary OSPAR. Place Published, OSPAR Convention for the Protection of the Marine Environement of North-East Atlanic.
EPA Toxic Release Inventory PBTsEPA (U.S. Environmental Protection Agency). 1999. Toxics Release Inventory Program. PBT Chemical Rule.
EPA PBTs - Waste Minimization Program (RCRA)EPA (U.S. Environmental Protection Agency). 1998. Resource Conservatin and Recovery Act (RCRA) Waste Minimization Program - priority chemicals for elimination or reduction.
EPA Integrated Risk Information System (IRIS)EPA (U.S. Environmental Protection Agency). 2008. Integrated Risk Information System (IRIS). Evidence for human carcinogenicity based on 1986-2005 guidelines.
California EPA Proposition 65California EPA (California Environmental Protection Agency). 9/2008. Office of Environmental Health Hazard Assessment. Safe Drinking Water and Toxic Enforcement Act of 1986. Chemicals known to the State to cause cancer or reproductive toxicity.
Scorecard.org Toxicity InformationProposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html.
European Commission on Endocrine DisruptionEU (European Union)- Strategy for Endocrine Disrupters 2007. Commision on endocrin disruption requested by the European Parliament in 1998.
RTECS®- Acta Morphologica Academiae Scientiarum Hungaricae 1979RTECS®- Acta Morphologica Academiae Scientiarum Hungaricae. (Budapest, Hungary) V.1-30, 1951-82. 27,199,1979
RTECS®- Biochemical Journal 1968RTECS®- Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 110,159,1968
RTECS®- Biochemical Pharmacology 1971RTECS®- Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 20,1297,1971
RTECS®- British Journal of Cancer 1978RTECS®- British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 37,873,1978
RTECS®- British Journal of Cancer 1979RTECS®- British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 39,540,1979
RTECS®- Cancer Letters (Shannon, Ireland) 1990RTECS®- Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 53,163,1990
RTECS®- Cancer Research 1973RTECS®- Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 33,2354,1973
RTECS®- Cancer Research 1978RTECS®- Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 38,2621,1978
RTECS®- Cancer Research 1980RTECS®- Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 40,1157,1980
RTECS®- Cancer Research 1981RTECS®- Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 41,532,1981
RTECS®- Cancer Research 1982RTECS®- Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 42,3676,1982
RTECS®- Carcinogenesis (London) 1984RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 5,231,1984
RTECS®- Carcinogenesis (London) 1984RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 5,747,1984
RTECS®- Chemical Mutagens 1980RTECS®- Chemical Mutagens. Principles and Methods for Their Detection. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 6,1,1980
RTECS®- Chemico-Biological Interactions 1972RTECS®- Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 4,389,1971/1972
RTECS®- Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology 1987RTECS®- Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 86,399,1987
RTECS®- Developments in Toxicology and Environtal Science 1982RTECS®- Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued 10,277,1982
RTECS®- Egyptian Journal of Genetics and Cytology 1975RTECS®- Egyptian Journal of Genetics and Cytology. (Egyptian Soc. of Genetics, c/o Alexandria Univ., Faculty of Agriculture, Dept. of Genetics, Alexandria, Egypt) V.1- 4,400,1975
RTECS®- Environmental and Molecular Mutagenesis 1988RTECS®- Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 12(Suppl 13),103,1988
RTECS®- Environmental Mutagenesis 1981RTECS®- Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. 3,11,1981
RTECS®- Environmental Mutagenesis 1982RTECS®- Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. 4,105,1982
RTECS®- Environmental Mutagenesis 1985RTECS®- Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. 7,137,1985
RTECS®- Huanjing Kexue Xuebao 1984RTECS®- Huanjing Kexue Xuebao. Environmental Sciences Journal. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 4,368,1984
RTECS®- International Journal of Cancer 1972RTECS®- International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 9,435,1972
RTECS®- JNCI, Journal of the National Cancer Institute 1979RTECS®- JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. 62,911,1979
RTECS®- JNCI, Journal of the National Cancer Institute 1979RTECS®- JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. 62,947,1979
RTECS®- JNCI, Journal of the National Cancer Institute 1980RTECS®- JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. 65,1321,1980
RTECS®- JNCI, Journal of the National Cancer Institute 1981RTECS®- JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. 67,1303,1981
RTECS®- Mutagenesis 2005RTECS®- Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 20,217,2005
RTECS®- Mutation Research 1987RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 192,239,1987
RTECS®- Mutation Research 1990RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 234,71,1990
RTECS®- Mutation Research 1993RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 290,175,1993
RTECS®- Mutation Research 1993RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 292,83,1993
RTECS®- Mutation Research 1994RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 312,165,1994
RTECS®- Mutation Research 1995RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 326,147,1995
RTECS®- Mutation Research 1998RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 419,91,1998
RTECS®- Mutation Research 1977RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 46,27,1977
RTECS®- Mutation Research 2002RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 515,85,2002
RTECS®- Mutation Research 2004RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 547,109,2004
RTECS®- Mutation Research 2004RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 557,99,2004
RTECS®- Mutation Research 2005RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 588,58,2005
RTECS®- Mutation Research 2005RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 588,7,2005
RTECS®- Mutation Research 2007RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 615,87,2007
RTECS®- Mutation Research 2007RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 626,88,2007
RTECS®- Mutation Research 2008RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 650,96,2008
RTECS®- Mutation Research 1979RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 66,65,1979
RTECS®- Mutation Research 1981RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 89,95,1981
RTECS®- Mutation Research 1981RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 91,467,1981
RTECS®- Proceedings of the National Academy of Sciences of the United States of America 1977RTECS®- Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 74,1378,1977
RTECS®- Proceedings of the National Academy of Sciences of the United States of America 1988RTECS®- Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 85,3513,1988
RTECS®- Tokyo Jikeikai Ika Daigaku Zasshi 1986RTECS®- Tokyo Jikeikai Ika Daigaku Zasshi. Tokyo Jikeikai Medical Journal. (3-25-8, Nishi Shinbashi, Minato-ku, Tokyo 105, Japan) V.66- 101,259,1986
RTECS®- Toxicology 1980RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 17,149,1980
RTECS®- Toxicology 2004RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 198,315,2004

"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.